Skip to main content
Top
Published in: BMC Cancer 1/2020

01-12-2020 | Nephrectomy | Research article

The effect of renal function change on renal cell carcinoma patients with tumor thrombus after nephrectomy and thrombectomy: a large Chinese center experience

Authors: Zhuo Liu, Shiying Tang, Xiaojun Tian, Hongxian Zhang, Guoliang Wang, Shudong Zhang, Lulin Ma

Published in: BMC Cancer | Issue 1/2020

Login to get access

Abstract

Background

To explore the influencing factors of perioperative renal function change and their relationship with prognosis on renal cell carcinoma (RCC) patients with tumor thrombus after nephrectomy and thrombectomy.

Methods

The clinical and pathological data of 135 patients with RCC and tumor thrombus, who underwent nephrectomy and thrombectomy at Peking University Third Hospital from May 2015 to July 2018, was retrospectively analyzed. Absolute change in estimated glomerular filtration rate (eGFR) (ACE) and percent change in eGFR (PCE) were calculated by preoperative and postoperative renal function. Linear regression analysis was used to explore the influencing factors of ACE and PCE, and logistic regression analysis was used to explore the influencing factors of worse postoperative renal function [eGFR≤60 mL/(min × 1.73 m^2)]. Cancer-specific survival (CSS) was estimated by Kaplan-Meier method and multivariate Cox regression, which were used to explore the effect of ACE and PCE on prognosis.

Results

Of all the 135 patients, 101 patients (74.8%) were male and 34 patients (25.2%) were female. The mean preoperative eGFR was 73.9 ± 21.8 mL/(min × 1.73 m^2) and postoperative eGFR was 69.5 ± 25.2 mL/(min × 1.73 m^2). In multivariate linear regression analysis, preoperative eGFR (P < 0.001) and pathological type (P = 0.038) were significant predictive factors of ACE. In aspect of PCE, preoperative eGFR (P < 0.001) and pathological type (P = 0.002) were significant predictors. In multivariate logistic regression analysis, preoperative eGFR (P = 0.016) was the only risk factor of predicting worse postoperative renal function. During follow-up, 22 patients (16.3%) were dead due to RCC. According to ROC analysis, the cut off value of ACE and PCE was 13.9 and 0.16, respectively. ACE> 13.9 and PCE > 0.16 indicated worse CSS (P = 0.006 and P = 0.047, respectively). However, in multivariate Cox regression analysis of several related factors, perinephric tissues invasion (P = 0.001), sarcomatoid differentiation (P = 0.001) and ACE> 13.9 (P = 0.002) were significant prognostic factors for CSS. PCE > 0.16 seemed to be not (P = 0.055).

Conclusion

We explored several clinicopathological risk factors of predicting renal function change and their relationship with prognosis of RCC patients with tumor thrombus after nephrectomy and thrombectomy. The renal function change, which was associated with preoperative eGFR and pathological type, was prognostic risk factor for CSS and ACE> 13.9 indicated the worse prognosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–24.PubMedCrossRef Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–24.PubMedCrossRef
2.
go back to reference Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on status of cancer in China, 2011. Chinese J Cancer Res. 2015;27(1):2–12.CrossRef Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on status of cancer in China, 2011. Chinese J Cancer Res. 2015;27(1):2–12.CrossRef
3.
go back to reference Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.PubMedCrossRef Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.PubMedCrossRef
4.
go back to reference Kümmerlin IPED, Laguna MP, JJMCHdl R, PMM B. Epidemiology of renal cell carcinoma. Scand J Surg. 2004;93(2):88.CrossRef Kümmerlin IPED, Laguna MP, JJMCHdl R, PMM B. Epidemiology of renal cell carcinoma. Scand J Surg. 2004;93(2):88.CrossRef
5.
go back to reference Bamias A, Tzannis K, Papatsoris A, et al. Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional study. Clin Genitourin Cancer. 2014;12(5):373–83.PubMedCrossRef Bamias A, Tzannis K, Papatsoris A, et al. Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional study. Clin Genitourin Cancer. 2014;12(5):373–83.PubMedCrossRef
6.
go back to reference Zabor EC, Furberg H, Lee B, et al. Long-term renal function recovery following radical nephrectomy for kidney Cancer: results from a multicenter confirmatory study. J Urol. 2018;199(4):921–6.PubMedCrossRef Zabor EC, Furberg H, Lee B, et al. Long-term renal function recovery following radical nephrectomy for kidney Cancer: results from a multicenter confirmatory study. J Urol. 2018;199(4):921–6.PubMedCrossRef
7.
go back to reference Sorbellini M, Kattan MW, Snyder ME, Hakimi AA, Sarasohn DM, Russo P. Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. J Urol. 2006;176(2):472–6 discussion 476.PubMedCrossRef Sorbellini M, Kattan MW, Snyder ME, Hakimi AA, Sarasohn DM, Russo P. Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. J Urol. 2006;176(2):472–6 discussion 476.PubMedCrossRef
8.
go back to reference Liss MA, DeConde R, Caovan D, et al. Parenchymal volumetric assessment as a predictive tool to determine renal function benefit of nephron-sparing surgery compared with radical nephrectomy. J Endourol. 2016;30(1):114–21.PubMedPubMedCentralCrossRef Liss MA, DeConde R, Caovan D, et al. Parenchymal volumetric assessment as a predictive tool to determine renal function benefit of nephron-sparing surgery compared with radical nephrectomy. J Endourol. 2016;30(1):114–21.PubMedPubMedCentralCrossRef
9.
go back to reference Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal Cancer: AUA guideline. J Urol. 2017;198(3):520–9.PubMedCrossRef Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal Cancer: AUA guideline. J Urol. 2017;198(3):520–9.PubMedCrossRef
10.
go back to reference Chung JS, Son NH, Byun SS, et al. Trends in renal function after radical nephrectomy: a multicentre analysis. BJU Int. 2014;113(3):408–15.PubMedCrossRef Chung JS, Son NH, Byun SS, et al. Trends in renal function after radical nephrectomy: a multicentre analysis. BJU Int. 2014;113(3):408–15.PubMedCrossRef
11.
go back to reference Jeon HG, Choo SH, Sung HH, et al. Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma. Eur J Cancer. 2014;50(1):64–9.PubMedCrossRef Jeon HG, Choo SH, Sung HH, et al. Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma. Eur J Cancer. 2014;50(1):64–9.PubMedCrossRef
12.
go back to reference Klarenbach S, Moore RB, Chapman DW, Dong J, Braam B. Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis. Eur Urol. 2011;59(3):333–9.PubMedCrossRef Klarenbach S, Moore RB, Chapman DW, Dong J, Braam B. Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis. Eur Urol. 2011;59(3):333–9.PubMedCrossRef
13.
go back to reference Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004;94(1):33–41.PubMedCrossRef Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004;94(1):33–41.PubMedCrossRef
14.
go back to reference Stevens LA, Schmid CH. Greene T, et al. comparative performance of the CKD epidemiology collaboration (CKD-EPI) and the modification of diet in renal disease (MDRD) study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis. 2010;56(3):486–95.PubMedPubMedCentralCrossRef Stevens LA, Schmid CH. Greene T, et al. comparative performance of the CKD epidemiology collaboration (CKD-EPI) and the modification of diet in renal disease (MDRD) study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis. 2010;56(3):486–95.PubMedPubMedCentralCrossRef
15.
go back to reference Haifler M, Ristau BT, Higgins AM, et al. External validation of contact surface area as a predictor of postoperative renal function in patients undergoing partial nephrectomy. J Urol. 2018;199(3):649–54.PubMedCrossRef Haifler M, Ristau BT, Higgins AM, et al. External validation of contact surface area as a predictor of postoperative renal function in patients undergoing partial nephrectomy. J Urol. 2018;199(3):649–54.PubMedCrossRef
16.
go back to reference Barbeito A, Muir HA, Gan TJ, et al. Use of a modifier reduces inconsistency in the American Society of Anesthesiologists Physical Status Classification in parturients. Anesth Analg. 2006;102(4):1231–3.PubMedCrossRef Barbeito A, Muir HA, Gan TJ, et al. Use of a modifier reduces inconsistency in the American Society of Anesthesiologists Physical Status Classification in parturients. Anesth Analg. 2006;102(4):1231–3.PubMedCrossRef
17.
go back to reference Mandal S, Sankhwar SN, Kathpalia R, et al. Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index. Int Urol Nephrol. 2013;45(2):347–54.PubMedCrossRef Mandal S, Sankhwar SN, Kathpalia R, et al. Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index. Int Urol Nephrol. 2013;45(2):347–54.PubMedCrossRef
18.
go back to reference Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of Tumours of the urinary system and male genital organs-part B: prostate and bladder Tumours. Eur Urol. 2016;70(1):106–19.PubMedCrossRef Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of Tumours of the urinary system and male genital organs-part B: prostate and bladder Tumours. Eur Urol. 2016;70(1):106–19.PubMedCrossRef
19.
go back to reference Hongo F, Oishi M, Ueda T, et al. MP57-09 impact of targeted therapy on renal function in patients with advanced renal cell cancer. J Urol. 2014;191(4):e645. Hongo F, Oishi M, Ueda T, et al. MP57-09 impact of targeted therapy on renal function in patients with advanced renal cell cancer. J Urol. 2014;191(4):e645.
20.
go back to reference Kawamura N, Yokoyama M, Fujii Y, et al. Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: a Japanese multicenter longitudinal study. Int J Urol. 2016;23(3):219–23.PubMedCrossRef Kawamura N, Yokoyama M, Fujii Y, et al. Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: a Japanese multicenter longitudinal study. Int J Urol. 2016;23(3):219–23.PubMedCrossRef
21.
go back to reference Clark AT, Breau RH, Morash C, Fergusson D, Doucette S, Cagiannos I. Preservation of renal function following partial or radical nephrectomy using 24-hour creatinine clearance. Eur Urol. 2008;54(1):143–9.PubMedCrossRef Clark AT, Breau RH, Morash C, Fergusson D, Doucette S, Cagiannos I. Preservation of renal function following partial or radical nephrectomy using 24-hour creatinine clearance. Eur Urol. 2008;54(1):143–9.PubMedCrossRef
22.
go back to reference Krebs RK, Andreoni C, Ortiz V. Impact of radical and partial nephrectomy on renal function in patients with renal cancer. Urol Int. 2014;92(4):449–54.PubMedCrossRef Krebs RK, Andreoni C, Ortiz V. Impact of radical and partial nephrectomy on renal function in patients with renal cancer. Urol Int. 2014;92(4):449–54.PubMedCrossRef
23.
go back to reference Yokoyama M, Fujii Y, Iimura Y, et al. Longitudinal change in renal function after radical nephrectomy in Japanese patients with renal cortical tumors. J Urol. 2011;185(6):2066–71.PubMedCrossRef Yokoyama M, Fujii Y, Iimura Y, et al. Longitudinal change in renal function after radical nephrectomy in Japanese patients with renal cortical tumors. J Urol. 2011;185(6):2066–71.PubMedCrossRef
24.
go back to reference Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. JASN. 2005;16(2):489–95.PubMedCrossRef Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. JASN. 2005;16(2):489–95.PubMedCrossRef
25.
go back to reference Tanaka N, Fujimoto K, Tani M, Yoshii M. Prediction of postoperative renal function by preoperative serum creatinine level and three-dimensional diagnostic image reconstruction in patients with renal cell carcinoma. Urology. 2004;64(5):904–8.PubMedCrossRef Tanaka N, Fujimoto K, Tani M, Yoshii M. Prediction of postoperative renal function by preoperative serum creatinine level and three-dimensional diagnostic image reconstruction in patients with renal cell carcinoma. Urology. 2004;64(5):904–8.PubMedCrossRef
26.
go back to reference Antoniewicz AA, Poletajew S, Borowka A, Pasierski T, Rostek M, Pikto-Pietkiewicz W. Renal function and adaptive changes in patients after radical or partial nephrectomy. Int Urol Nephrol. 2012;44(3):745–51.PubMedCrossRef Antoniewicz AA, Poletajew S, Borowka A, Pasierski T, Rostek M, Pikto-Pietkiewicz W. Renal function and adaptive changes in patients after radical or partial nephrectomy. Int Urol Nephrol. 2012;44(3):745–51.PubMedCrossRef
27.
go back to reference Shirasaki Y, Tsushima T, Saika T, Nasu Y, Kumon H. Kidney function after nephrectomy for renal cell carcinoma. Urology. 2004;64(1):43–7 discussion 48.PubMedCrossRef Shirasaki Y, Tsushima T, Saika T, Nasu Y, Kumon H. Kidney function after nephrectomy for renal cell carcinoma. Urology. 2004;64(1):43–7 discussion 48.PubMedCrossRef
28.
go back to reference Lane BR, Novick AC, Babineau D, Fergany AF, Kaouk JH, Gill IS. Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. J Urol. 2008;179(3):847–51 discussion 852.PubMedCrossRef Lane BR, Novick AC, Babineau D, Fergany AF, Kaouk JH, Gill IS. Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. J Urol. 2008;179(3):847–51 discussion 852.PubMedCrossRef
29.
go back to reference Nouh MA, Kuroda N, Yamashita M, et al. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis. BJU Int. 2010;105(5):620–7.PubMedCrossRef Nouh MA, Kuroda N, Yamashita M, et al. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis. BJU Int. 2010;105(5):620–7.PubMedCrossRef
30.
go back to reference Woldu SL, Weinberg AC, RoyChoudhury A, et al. Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology. Int Urol Nephrol. 2014;46(11):2127–32.PubMedCrossRef Woldu SL, Weinberg AC, RoyChoudhury A, et al. Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology. Int Urol Nephrol. 2014;46(11):2127–32.PubMedCrossRef
31.
go back to reference Tang Q, Song Y, Li X, et al. Prognostic outcomes and risk factors for patients with renal cell carcinoma and venous tumor Thrombus after radical nephrectomy and Thrombectomy: the prognostic significance of venous tumor Thrombus level. Biomed Res Int. 2015;2015:163423.PubMedPubMedCentral Tang Q, Song Y, Li X, et al. Prognostic outcomes and risk factors for patients with renal cell carcinoma and venous tumor Thrombus after radical nephrectomy and Thrombectomy: the prognostic significance of venous tumor Thrombus level. Biomed Res Int. 2015;2015:163423.PubMedPubMedCentral
Metadata
Title
The effect of renal function change on renal cell carcinoma patients with tumor thrombus after nephrectomy and thrombectomy: a large Chinese center experience
Authors
Zhuo Liu
Shiying Tang
Xiaojun Tian
Hongxian Zhang
Guoliang Wang
Shudong Zhang
Lulin Ma
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2020
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-020-6563-7

Other articles of this Issue 1/2020

BMC Cancer 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine